The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Sandoz
Stock and Other Ownership Interests - Sandoz

A cost-effectiveness analysis of primary prophylaxis (PP) versus secondary prophylaxis (SP) with biosimilar myeloid growth factors (MGFs) for preventing chemotherapy-induced febrile neutropenia (FN) in non-Hodgkin lymphoma (NHL) patients at intermediate risk.
 
Gary H. Lyman
Stock and Other Ownership Interests - Generex Biotechnology
Consulting or Advisory Role - Agendia; Amgen; Celldex (I); G1 Therapeutics; Genomic Health; Halozyme; Helsinn Therapeutics; Janssen (I); Mylan; Partners Healthcare; Pfizer; Samsung Bioepis; Spectrum Pharmaceuticals
Research Funding - Hexal
 
Dylan Mezzio
Employment - Xcenda
 
Edward C. Li
Employment - Sandoz
Honoraria - Apobiologix; Lilly; Mylan; Pfizer; Sandoz
Consulting or Advisory Role - New Century Health (Inst)
Speakers' Bureau - Pfizer
 
Kim Campbell
No Relationships to Disclose
 
Sanjeev Balu
Employment - Sandoz
Stock and Other Ownership Interests - Sandoz